Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Anagrelide

An imidazoquinazoline derivative that lowers the platelet count by slowing the maturation of megakaryocytes in the bone marrow: approved in the United States in 1997 for essential thrombocythaemia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It was developed as an antiplatelet agent, but studies showed that it reduced the number of platelets: the unexpected effect became its main indication.

Anagrelide HydrochlorideGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.